| | 84611-23-4 Basic information More.. |
| Product Name: | Erdosteine | | Synonyms: | 2-[[2-Oxo-2-[(tetrahydro-2-oxo-3-thienyl)aMino]ethyl]thio]acetic Acid;Dithiosteine;Aceticacid, 2-[[2-oxo-2-[(tetrahydro-2-oxo-3-thienyl)aMino]ethyl]thio]-;2-[2-OXO-2-(2-OXO-TETRAHYDROTHIOPHEN-3-YLAMINO)ETHYLTHIO]ACETIC ACID;[[2-oxo-2-[(tetrahydro-2-oxo-3-thienyl)amino]ethyl]thio]acetic acid;ERDOSTEINE BP98;[[(Tetrahydro-2-oxothiophene-3-yl)carbamoyl]methylthio]acetic acid;[[2-Oxo-2-[[(2-oxotetrahydrothiophen)-3-yl]amino]ethyl]thio]acetic acid | | CAS: | 84611-23-4 | | MF: | C8H11NO4S2 | | MW: | 249.31 | | EINECS: | 642-172-5 | | Mol File: | 84611-23-4.mol |  |
Use
Erdosteine is a new expectorant introduced in France for the treatment
of chronic bronchitis. Erdosteine possesses mucomodulator, mucolytic, mucokinetic
and free radical scavenging properties. Its therapeutic efficacy has been
demonstrated in patients affected by congestion and viscous mucus in higher and lower
respiratory tracts as in acute and chronic bronchitis, sinusitis, otitis,
tracheopharyngitis and coryza. Erdosteine acts through its active metabolites
containing free sulfhydryl groups which are able to depolymerize the
mucopolysaccharides of the excreatum by breaking the disulfide linkages (thereby
lowing its viscosity). The prodrug approach provides unique characteristics to
erdosteine by offering stable therapeutic efficacy and prevention of the gastric mucus
from lythic phenomena. The agent was also reported to have local antiinflammatory and
antielastase properties and enhances penetration of antibiotics into bronchial mucus.
- Erdosteine
-
- US $55.00 / KG
- 2023-03-27
- CAS:84611-23-4
- Min. Order: 1KG
- Purity: 99.9%
- Supply Ability: 500MT/month
- Erdosteine
-
- US $0.00-0.00 / kg
- 2022-10-18
- CAS:84611-23-4
- Min. Order: 1kg
- Purity: 98%
- Supply Ability: 1Ton
- Erdosteine
-
- US $15.00-10.00 / KG
- 2021-08-12
- CAS:84611-23-4
- Min. Order: 1KG
- Purity: 99%+ HPLC
- Supply Ability: Monthly supply of 1 ton
|
|
84611-23-4
Recommend Suppliers |
|